HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 294/1/E148    most recent 00211.2007v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (20) Citing Articles via Google Scholar Google Scholar Articles by Yin, J. Articles by Ye, J. Search for Related Content PubMed PubMed Citation Articles by Yin, J. Articles by Ye, J.

Berberine improves glucose metabolism through induction of glycolysis

¹Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge, Louisiana; ²Shanghai Institute of Endocrinology and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University Medical School, Shanghai, China; and ³Medicinal Plant Research Laboratory, School of Renewable Natural Resources, Louisiana State University Agricultural Center, Baton Rouge, Louisiana

Submitted 5 April 2007 ; accepted in final form 19 October 2007

Berberine, a botanical alkaloid used to control blood glucose in type 2 diabetes in China, has recently been reported to activate AMPK. However, it is not clear how AMPK is activated by berberine. In this study, activity and action mechanism of berberine were investigated in vivo and in vitro. In dietary obese rats, berberine increased insulin sensitivity after 5-wk administration. Fasting insulin and HOMA-IR were decreased by 46 and 48%, respectively, in the rats. In cell lines including 3T3-L1 adipocytes, L6 myotubes, C₂C₁₂ myotubes, and H4IIE hepatocytes, berberine was found to increase glucose consumption, 2-deoxyglucose uptake, and to a less degree 3-O-methylglucose (3-OMG) uptake independently of insulin. The insulin-induced glucose uptake was enhanced by berberine in the absence of change in IRS-1 (Ser^307/312), Akt, p70 S6, and ERK phosphorylation. AMPK phosphorylation was increased by berberine at 0.5 h, and the increase remained for 16 h. Aerobic and anaerobic respiration were determined to understand the mechanism of berberine action. The long-lasting phosphorylation of AMPK was associated with persistent elevation in AMP/ATP ratio and reduction in oxygen consumption. An increase in glycolysis was observed with a rise in lactic acid production. Berberine exhibited no cytotoxicity, and it protected plasma membrane in L6 myotubes in the cell culture. These results suggest that berberine enhances glucose metabolism by stimulation of glycolysis, which is related to inhibition of glucose oxidation in mitochondria. Berberine-induced AMPK activation is likely a consequence of mitochondria inhibition that increases the AMP/ATP ratio.

type 2 diabetes; insulin sensitivity; oxygen consumption; mitochondrial function; adenosine 5'-monophosphate-activated protein kinase

This article has been cited by other articles:

				J. Xu and M.-H. Zou Molecular Insights and Therapeutic Targets for Diabetic Endothelial Dysfunction Circulation, September 29, 2009; 120(13): 1266 - 1286. [Full Text] [PDF]

				G. R. Steinberg and B. E. Kemp AMPK in Health and Disease Physiol Rev, July 1, 2009; 89(3): 1025 - 1078. [Abstract] [Full Text] [PDF]

				J. Yin, A. Zuberi, Z. Gao, D. Liu, Z. Liu, and J. Ye Shilianhua extract inhibits GSK-3{beta} and promotes glucose metabolism Am J Physiol Endocrinol Metab, June 1, 2009; 296(6): E1275 - E1280. [Abstract] [Full Text] [PDF]

				Y. Wang, Y. Huang, K. S.L. Lam, Y. Li, W. T. Wong, H. Ye, C.-W. Lau, P. M. Vanhoutte, and A. Xu Berberine prevents hyperglycemia-induced endothelial injury and enhances vasodilatation via adenosine monophosphate-activated protein kinase and endothelial nitric oxide synthase Cardiovasc Res, June 1, 2009; 82(3): 484 - 492. [Abstract] [Full Text] [PDF]

				W. S. Kim, Y. S. Lee, S. H. Cha, H. W. Jeong, S. S. Choe, M.-R. Lee, G. T. Oh, H.-S. Park, K.-U. Lee, M. D. Lane, et al. Berberine improves lipid dysregulation in obesity by controlling central and peripheral AMPK activity Am J Physiol Endocrinol Metab, April 1, 2009; 296(4): E812 - E819. [Abstract] [Full Text] [PDF]

				H. W. Jeong, K. C. Hsu, J.-W. Lee, M. Ham, J. Y. Huh, H. J. Shin, W. S. Kim, and J. B. Kim Berberine suppresses proinflammatory responses through AMPK activation in macrophages Am J Physiol Endocrinol Metab, April 1, 2009; 296(4): E955 - E964. [Abstract] [Full Text] [PDF]

				J. Yin, Z. Gao, Q. He, D. Zhou, Z. Guo, and J. Ye Role of hypoxia in obesity-induced disorders of glucose and lipid metabolism in adipose tissue Am J Physiol Endocrinol Metab, February 1, 2009; 296(2): E333 - E342. [Abstract] [Full Text] [PDF]

				F. Qiu, Z. Zhu, N. Kang, S. Piao, G. Qin, and X. Yao Isolation and Identification of Urinary Metabolites of Berberine in Rats and Humans Drug Metab. Dispos., November 1, 2008; 36(11): 2159 - 2165. [Abstract] [Full Text] [PDF]

				N. Turner, J.-Y. Li, A. Gosby, S. W.C. To, Z. Cheng, H. Miyoshi, M. M. Taketo, G. J. Cooney, E. W. Kraegen, D. E. James, et al. Berberine and Its More Biologically Available Derivative, Dihydroberberine, Inhibit Mitochondrial Respiratory Complex I: A Mechanism for the Action of Berberine to Activate AMP-Activated Protein Kinase and Improve Insulin Action Diabetes, May 1, 2008; 57(5): 1414 - 1418. [Abstract] [Full Text] [PDF]